[Alsalem, B. (2019). The diagnostic utility of cancer stem cell marker CD44 in early detection of oral cancer. Dissertation, Thesis Master of Science, University of Maryland, Baltimore. https://archive.hshsl.umaryland.edu/handle/10713/11708 (accessed 20.03.2021).]Search in Google Scholar
[Ambele, M. A,, van Zyl, A., Pepper, M. S., van Heerden, M. B., Heerden, W. F. P. (2020). Amplification of 3q26.2, 5q14.3, 8q24.3, 8q22.3, and 14q32.33: Are possible common genetic alterations in oral cancer patients. Frontiers Oncol., 10, 1-8.10.3389/fonc.2020.00683720347932426287]Search in Google Scholar
[Alves, C. S., Yakovlev, S., Medved, L., Konstantopoulos, K. (2009). Bio-molecular characterization of CD44-fibrin(ogen) binding: Distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen). J. Biol Chem.,284 (2), 1177–1189.10.1074/jbc.M805144200261361019004834]Search in Google Scholar
[Anonymous (2020). GLOBOCAN, 2018. http://gco.iarc.fr (accessed 29.06.2020).]Search in Google Scholar
[Assimakopoulos, D., Kolettas, E., Patrikakos, G., Evangelou, A. (2002). The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas. Histol. Histopathol., 17 (4), 1269–1281.]Search in Google Scholar
[Boxberg, M., Götz, C., Haidari S., Dorfner, C., Jesinghaus, M., Drecoll, E., Boskov, M., Wolff, K. D., Weichert, W., Haller, B., Kolk, A. (2018). Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors. Histopathology, 73 (4), 559–572.10.1111/his.1349629468726]Search in Google Scholar
[Chen, D., Cun-YuWang, C.-Y (2019). CD44 and ALDH1 immuno-expression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma. Precision Clin. Med., 2 (3), 152–165.10.1093/pcmedi/pbz016677027731598386]Search in Google Scholar
[Diz, P., Meleti, M., Diniz-Freitas, M., Vescovi, P., Warnakulasuriya, S., Johnson, N. W., Kerr, A. K. (2017). Oral and pharyngeal cancer in Europe: Incidence, mortality and trends as presented to the Global Oral Cancer Forum. Transl. Res. Oral Oncol., 2, 1–310.1177/2057178X17701517]Search in Google Scholar
[Garcia, A. S., Assao, A., Carvalho, A. L., Soares F. A., Koalski L. P., Oliveira D. T. (2019). The stem cell markers expression CD44v6 and podoplanin in lip cancer: Clinical significance. Virchows Arch., 474 (6), 745–754.10.1007/s00428-019-02539-330770986]Search in Google Scholar
[Godge, P. Y., Poonja L. S. (2011). Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study. Indian J. Dent Res.,22 (3), 493–49410.4103/0970-9290.8708022048598]Search in Google Scholar
[Gore, Y., Starlets, D., Maharshak, N., Becker-Herman, S., Kaneyuki, U., Leng, L., Bucala, R., Shachar, I. (2008). Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem., 283 (5), 2784–2792.10.1074/jbc.M70326520018056708]Search in Google Scholar
[Groma, V., Kazanceva, A., Krukle, Z. N., Murovska, M. (2012). Oropharyngeal malignant epithelial cell, lymphocyte, and macrophage CD44 surface receptors for hyaluronate are expressed in sustained EBV infection: Immunohistochemical data and EBV DNA tissue indices. Pathol. Res. Practice,208 (9), 518–526.10.1016/j.prp.2012.05.01722770970]Search in Google Scholar
[Harada, H., Takahashi, M. (2007). CD44-dependeent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J. Biol. Chem., 282, 5597–5607.10.1074/jbc.M60835820017170110]Search in Google Scholar
[Herold-Mende, C., Seiter, S., Born, A. I., Patzelt, E., Schupp, M., Zölle, J., Bosch, F. X., Zöller, M. (1996). Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J. Pathol., 179 (1), 66–73.10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5]Search in Google Scholar
[Jakovlevs, A., Vanags, A., Gardovskis, J., Strumfa, I. (2019). Molecular classification of diffuse gliomas. Pol. J. Pathol., 70 (4), 246–258.10.5114/pjp.2019.93126]Search in Google Scholar
[Johnson, P., Ruffell, B. (2009). CD44 and its role in inflammation and inflammatory diseases. Inflamm. Allergy-Drug Targets, 8 (3), 208–220.10.2174/187152809788680994]Search in Google Scholar
[Kaza, S., Kantheti, L. P., Poosarla, C., Gontu, S. R., Kattappagari, K. K., Baddam, V. R. (2018). A study on the expression of CD44 adhesion molecule in oral squamous cell carcinoma and its correlation with tumor histological grading. J. Orofac. Sci., 10, 42–49.]Search in Google Scholar
[Khajuria, N., Metgud, R. (2015). Role of bacteria in oral carcinogenesis. Indian J. Dent., 6 (1), 37–43.10.4103/0975-962X.151709]Search in Google Scholar
[Lindquist, D., Ahrlund-Richter, A., Tarjįn, M., Tot, T., Dalianis, T. (2012). Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer. Anticancer Res. Act., 32 (1), 153–161.]Search in Google Scholar
[Miletti-González, K. E., Murphy, K., Kumaran, M. N., Ravindranath, A. K., Wernyj, R. P., Kaur, S., Miles, G. D., Lim, E., Chan, R., Chekmareva, M., Heller, D. S., Foran, D., Chen, W., Reiss, M., Bandera, E. V., Kathleen Scotto, K., Rodríguez-Rodríguez, L. (2012). Identification of function for CD44 intracytoplasmic domain (CD44-ICD): Modulation of matrix metalloproteinase (MMP-9) transcription via novel promoter response element. J. Biol. Chem., 287 (23), 18995–19007.10.1074/jbc.M111.318774]Search in Google Scholar
[Naga, S. K. S. V., Shekar, P. C., Kattappagari, K. K., Chandra, K. L. P., Reddy, G. S., Reddy, B. V. R. (2019). Expression of cluster differentiation-44 stem cell marker in grades of oral epithelial dysplasia: A preliminary study. J. Oral Maxillofac. Pathol., 23 (2), 203–207.]Search in Google Scholar
[Nanci A. (2017). Ten Cate’s Oral Histology: Development, Structure and Function.9th edn. St. Luis, Elsevier. 352 pp.]Search in Google Scholar
[Narayan, T. V., Shilpashree, S. (2016). Meta-analysis on clinicopathologic risk factors of leukoplakias undergoing malignant transformation. J. Oral Maxillofac. Pathol.,20 (3), 354–361.]Search in Google Scholar
[Negi, L. M., Talegaonkar, S., Jaggi, M., Iqbalz. Z., Khar, R. K. (2012). Role of CD44 in tumour progression and strategies for targeting. J. Drug Target., 20, 561–573.10.3109/1061186X.2012.702767]Search in Google Scholar
[Ortiz, R. C., Lopes, N. M., Amor, N. G., José, B. P., Schmerling, C. K., Lara V. S., Moyses, R. A., Rodini, C. O. (2018). CD44 and ALDH1 immuno-expression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma. J. Oral Pathol. Med., 47, 740–747.10.1111/jop.12734]Search in Google Scholar
[Pettersen, J. S., Fuentes-Duculan, J., Suįrez-Farińas, M., Pierson, K. C., Pitts-Kiefer, A., Fan, L., Belkin, D. A., Wang, C. Q. F., Bhuvanendran, S., Johnson-Huang, L. M., Bluth, M. J., Krueger, J. G., Lowes, M. A., Carucci, J. A. (2011). Tumor-associated macrophages in the cutaneous SCC micro-environment are heterogeneously activated. J. Invest. Dermat., 131 (6),1322–1330.10.1038/jid.2011.9]Search in Google Scholar
[Pisterna, G. V., Siragusa, M. (2007). CD44 presence in inflamed pulp tissue. J. Endod., 33 (10), 1203–1207.10.1016/j.joen.2007.05.022]Search in Google Scholar
[Puré, E., Oaff, C. A. (2001). A crucial role for CD44 in inflammation. Trends Mol. Med., 7 (5), 213–221.10.1016/S1471-4914(01)01963-3]Search in Google Scholar
[Reid, P., Marcu, L. G., Olve, I., Moghaddasi, L., Staudacher, A. H., Bezak, E. (2019). Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response. Radiother. Oncol.,135, 1–12.10.1016/j.radonc.2019.02.016]Search in Google Scholar
[Renaud-Vilmer, C., Cavelier-Balloy, B. (2017). Precancerous lesions of the buccal epithelium. Ann. Dermatol. Venereol., 144 (2), 100–108.10.1016/j.annder.2016.07.017]Search in Google Scholar
[Roye, D. G., Myers, R. B., Brown, D., Poczatek, D. R., Beenken S. W., Grizzle, W. E. (1996). CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int. J. Cancer, 69, 254–258.10.1002/(SICI)1097-0215(19960822)69:4<254::AID-IJC2>3.0.CO;2-W]Search in Google Scholar
[Speight, P. M., Khurram, S. A., Kujan, O. (2018). Oral potentially malignant disorders: Risk of progression to malignancy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol., 125 (6), 612–627.10.1016/j.oooo.2017.12.011]Search in Google Scholar
[Sundberg, J., Korytowska, M., Holmberg, E., Bratel, J., Wallström, M., Kjellström, E., Blomgren, J., Kovįcs, A., Öhman, J., Sand, L., Hirsch, J.-M., Giglio, D., Kjeller, G., Bengt Hasséus, B. (2019). Recurrence rates after surgical removal of oral leukoplakia: A prospective longitudinal multi-centre study. PLoS One, 14 (12), e0225682.10.1371/journal.pone.0225682]Search in Google Scholar
[Tamatani, T., Takamaru, N., Ohe, G., Akita, K., Nakagawa, T., Miyamoto, Y. (2018). Express of CD44, CD44v9, ABCG2, CD24, Bmi-1 and ALDH1 instage I and II oral squamous cell carcinoma and their association with clinicopathological factors. Oncol. Lett., 16 (1),1133–1140.]Search in Google Scholar
[Wang, S. J., Wong, G, de Heer G. A. M., Xia W, Bourguignon, L.Y. (2009). CD44 variant isoforms in head and neck squamous cell carcinoma progression. The Laryngoscope, 119 (8), 1518–1530.10.1002/lary.20506]Search in Google Scholar
[Warnakulasuriya S. (2009). Global epidemiology of oral and oropharyngeal cancer. Oral. Oncol., 45 (4–5), 309–316.10.1016/j.oraloncology.2008.06.002]Search in Google Scholar
[Wielenga, V. J. M., Heider, K-H., Offerhaus, G. J. A., Adolf, G. R., Berg, F. M., Punta, H., Herrlich, P., Steven T. Pals, S. T. (1993). Advances in brief expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Research, 53, 4754–4756.]Search in Google Scholar